Navigation Links
Delcath To Offer Second Generation Hemofiltration Cartridge In U.S. Expanded Access Program
Date:6/18/2012

NEW YORK, June 18, 2012 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) today announced that the Company has amended its Investigational New Drug (IND) application and its Expanded Access Program (EAP) to include the use of the second-generation hemofiltration cartridge of the Company's proprietary chemosaturation system. The amendments filed with the U.S. Food and Drug Administration (FDA) will permit physicians to use the second-generation system in expanded access and compassionate use cases in selected cancer centers trained in the use of the Delcath system. The amendments also permit the use of the second-generation system in clinical trials the Company has planned as part of its Clinical Development Program. Previously, only the first-generation system used in Delcath's clinical trials was available for individual compassionate use cases.

Under the Expanded Access Protocol, eligible patients will be able to receive treatment through enrollment at participating cancer centers. These centers will be able to begin treating patients upon receipt of institutional review board (IRB) approval which the company expects most centers will receive in the third quarter of 2012.

The second-generation hemofiltration cartridge has demonstrated greater efficiency in melphalan removal from the blood in bench-top and in vivo porcine studies. The Company believes that if filtration efficiency is validated in clinical use, the second-generation system may significantly reduce melphalan-associated bone marrow toxicity noted in prior clinical trials.

"We believe it is in the best interest of patients to accelerate availability of the second generation filter for investigational uses in the U.S.," said Eamonn P. Hobbs, President & CEO of Delcath Systems. "We are encouraged by the reports on initial patient treatments in Italy and Germany, where physicians h
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Systems, Inc. Secures $20 Million Credit Facility
2. Delcath Highlights First Quarter 2012 And Recent Accomplishments
3. Delcath to Webcast Managements Presentation at Annual Meeting of Stockholders
4. Delcath Prices $20 Million Public Offering of Common Stock and Warrants
5. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
6. Two Top Notch Cadaver Workshops Offered by joimax® in April
7. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
8. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
9. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
10. Cochlear™ Americas Adds the Nucleus® Support App to its Mobile Service Offerings
11. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014 /CNW/ - On Aug. ... , the Canadian Medical Association (CMA) voted on ... any plant material, including medicinal cannabis. Bedrocan Cannabis Corp., ... supportive of the CMA motion. The CMA ... particular hazards associated with smoking any plant material, including ...
(Date:8/22/2014)...   Zacks Equity Research highlights Epizyme (Nasdaq: EPZM ... Panera (Nasdaq: PNRA - Free Report ) as the Bear ... Amicus Therapeutics (Nasdaq: FOLD - Free Report ), Sanofi (NYSE: ... - Free Report ). Here is a synopsis of ... : The biotech bull market is far from ...
(Date:8/22/2014)... Aug. 22, 2014  Cannabis Science, Inc. (OTC: ... drug development and related consulting, is pleased to ... medical cannabis conference taking place at the Faculty ... , on October 22, 2014.  The multilingual conference ... as researchers, health professionals, and patients, to discuss ...
Breaking Medicine Technology:Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3
... Results Reported at American Association for Dental Research ... Parion Sciences, Inc., a,privately-held, development-stage pharmaceutical company dedicated ... body,s mucosal,defenses, today announced preliminary results from a ... channel blocker, P-552-02, as a topical,therapy for dry ...
... April 7 A biosimilar product for,treating the ... the,white blood cells of patients is safe and ... a reference,product. This is the result of a ... company Kwizda Pharma GmbH and the Indian manufacturer,INTAS ...
Cached Medicine Technology:Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 2Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 3Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market 2Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market 3
(Date:8/23/2014)... The MPWMD Board of Directors voted on Monday, August 18th ... of water for commercial and industrial properties. This was ... Archworks, LLC in Carmel, California. , This is a ... district in the State of California has approved this technology ... this time can now be used as a sole source ...
(Date:8/23/2014)... Athens, GA (PRWEB) August 23, 2014 Young adults ... drinking or doing drugs should pick up the phone and call ... troubled teen drug addict . , Troubled Teen Athens ... who is ready to finally take the necessary steps to end ... help, they are quick to go to friends or peers when ...
(Date:8/23/2014)... Wilmington, NC (PRWEB) August 23, 2014 ... across North Carolina. It’s no different in Wilmington, NC. ... Young adults are falling victim to drug and alcohol ... young people are looking to overcome substance abuse, but ... Finding an adolescent treatment facility can be a challenge ...
(Date:8/22/2014)... 23, 2014 Search Engine Optimization ... first page of search engines and get more ... has recently compared many Linux hosting suppliers and ... are the most recommended Linux hosting suppliers for ... Europe to buy high quality Linux hosting (including ...
(Date:8/22/2014)... On Friday, Aug. 22, Liberty University unveiled ... , hosting a ceremony in its courtyard attended by ... public welfare. , The 162-member inaugural class of the ... joined Liberty staff, faculty, and community leaders in celebrating ... medical school. Classes began on Monday, Aug. 4. , ...
Breaking Medicine News(10 mins):Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:Teenagers in Athens, GA are Locating Addiction Recovery Thanks to New Helpline 2Health News:Troubled Teens Wilmington Helpline Guides Adolescents to the Path of Recovery 2Health News:Top10BestSEOHosting.com Announces Best Cheap Hosting Suppliers Of This Summer 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 3Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 4
... Allscripts-Misys Healthcare,Solutions, Inc. (formerly named Allscripts Healthcare ... Delaware ("Allscripts") and,headquartered in Chicago, Illinois, announced today ... all of its 3.50% Convertible Senior Debentures,due 2024 ... 100% of the principal,amount of the Debentures being ...
... Watch and Jim Shank attribute the change to public outrage ... , WASHINGTON, Dec. 10 Wal-Mart Watch claimed ... a subrogation exception to the company,s 2009 health care plan ... Debbie Shank. , , ...
... ON. For the first time ever, an international ... the world,s tallest mountain, shedding some light on what ... on earth. , The team,s surprising findings shatter commonly-held ... falling ice and pulmonary oedema (lung problems) and highlight ...
... T ),has announced a contribution of A$38,000 ... support disadvantaged children in Australia. This is,the fifth ... Founded,in 1922, The Smith Family is a national, independent ... a better future,through education. , ...
... the United Kingdom and hires Michael Dyson to run European operations. ... ... -- DNA2.0, the leading gene synthesis and protein engineering company, today ... of the United Kingdom-based DNA2.0 Ltd. Michael Dyson, PhD, has been ...
... (duloxetine HCl) 60 mg to 120 mg once daily ... patients who had previously responded to the,medication and who ... patients who experienced at least three depressive episodes in ... Results from the 52-,week maintenance phase of the ...
Cached Medicine News:Health News:Allscripts Announces Expiration of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 2Health News:Wal-Mart's 2009 Health Care Plan Includes 'Debbie Shank Exception' 2Health News:Wal-Mart's 2009 Health Care Plan Includes 'Debbie Shank Exception' 3Health News:Team probes why climbers die on Mount Everest 2Health News:AT&T Supports the Smith Family's Learning For Life Program 2Health News:AT&T Supports the Smith Family's Learning For Life Program 3Health News:AT&T Supports the Smith Family's Learning For Life Program 4Health News:DNA2.0 Expands European Presence By Opening UK Office: Experienced Life Sciences Executive, Dr. Michael Dyson, to Lead European Operations 2Health News:Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R) 2Health News:Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R) 3Health News:Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R) 4Health News:Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R) 5Health News:Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R) 6
An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45,...
Rapid test for the presumptive identification of Candida albicans from culture media....
... is a system built ... and an imaging device ... zone size around an ... built-in expertise for detection ...
The best value and features offered in a complete EMR and Practice Management Solution...
Medicine Products: